Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
JAMA Oncology|May 23, 2024
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled TrialNabil F Saba, Stuart J Wong, Tahseen Nasti, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2024
Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and databaseSujith Baliga, Ahmad K Abou-Foul, Pablo Parente, et al.
Annals of Surgery|August 7, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon CancerStacey A Cohen, Vasily N Aushev, George Laliotis, et al.
Bone Marrow Transplantation|December 12, 2018
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Bone Marrow Transplantation|February 28, 2019
Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 7, 2018
Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow TransplantationYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Signal Transduction and Targeted Therapy|April 7, 2026
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 studyShuang Huang, Feng Liu, Song Qu, et al.
Pageof 4